Häuser W, Ablin J, Fitzcharles MA, Littlejohn G, Luciano JV, Usui C. Fibromyalgia. Nat Rev Dis Primers. 2015;1:15022.

Marques AP, Santo AS Espírito, Berssaneti AA, Matsutani LA, Yuan SLK. A prevalência de fibromialgia: atualização da revisão de literatura. Rev Bras Reumatol. 2017;57(4):356-63.

Heymanna RE, Paiva ES, Martineza JE, Helfenstein Jr M, Rezende MC, Provenza JR. Novas diretrizes para o diagnóstico da fibromialgia. Rev Bras Reumatol. 2017;57(2):S467-76.

Ovayolu N, Ovayolu O, Karadag G. Health-related quality of life in ankylosing spondylitis, fibromyalgia syndrome, and rheumatoid arthritis: a comparison with a selected sample of healthy individuals. Clin Rheumatol. 2011;30(5):655-64.

Skaer TL. Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden. Pharmacoeconomics. 2014;32(5):457-66.

Silverman S, Dukes EM, Johnston SS, Brandenburg NA, Sadosky A, Huse DM. The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis. Curr Med Res Opin. 2009;25(4):829-40.

Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547-55.

Bradley LA. Pathophysiology of fibromyalgia. Am J Med. 2009;122(12^sSuppl):S22-30.

Chakr RM, Xavier RM. Fibromialgia: princípios práticos que auxiliam na indicação e no ajuste do tratamento medicamentoso. J Bras Med. 2014;102(6):23-9.

Harding SM. Sleep in fibromyalgia patients: subjective and objective findings. Am J Med Sci. 1998;315(6):367-76.

Bennett RM, Clark SR, Campbell SM, Burckhardt CS. Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain. Arthritis Rheum. 1992;35(1):1113-6.

Davies KA, Macfarlane GJ, Nicholl BI, Dickens C, Morriss R, Ray D. Restorative sleep predicts the resolution of chronic widespread pain: results from the EPIFUND study. Rheumatology. 2008;47(1):1809-13.

Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318-28.

Üçeyler N, Sommer C, Walitt B, Häuser W. WITHDRAWN: anticonvulsants for fibromyalgia. Cochrane Database Syst Rev. 2017:CD010782.

Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009:CD007076.

Lloyd A, Boomershine CS, Choy EH, Chandran A, Zlateva G. The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective. J Med Econ. 2012;15(3):481-92.

Bhusal S, Diomampo S, Magrey MN. Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia. Drug Healthc Patient Saf. 2016;17(8):13-23.

Bigatti SM, Hernandez AM, Cronan TA, Rand KL. Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression. Arthritis Rheum. 2008;59(7):961-7.

C-oté KA, Moldofsky H. Sleep, daytime symptoms, and cognitive performance in patients with fibromyalgia. J Rheumatol. 1997;24(10):2014-23.

Burns JW, Crofford LJ, Chervin RD. Sleep stage dynamics in fibromyalgia patients and controls. Sleep Med. 2008;9(6):689-96.

Diaz-Piedra C, Catena A, Sánchez AI, Miró E, Martínez MP, Buela-Casal G. Sleep disturbances in fibromyalgia syndrome: the role of clinical and polysomnographic variables explaining poor sleep quality in patients. Sleep Med. 2015;16(8):917-25.

Choy EH. The role of sleep in pain and fibromyalgia. Nat Rev Rheumatol. 2015;11(9):513-20.

Osorio CD, Gallinaro AL, Lorenzi-Filho G, Lage LV. Sleep quality in patients with fibromyalgia using the Pittsburgh Sleep Quality Index. J Rheumatol. 2006;33(9):1863-5.

Rener-Sitar K, John MT, Pusalavidyasagar SS, Bandyopadhyay D, Schiffman EL. Sleep quality in temporomandibular disorder cases. Sleep Med. 2016;25:105-12.

Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia. 2004;45(6):13-8.

Kim L, Lipton S, Deodhar A. Pregabalin for fibromyalgia: some relief but no cure. Cleve Clin J Med. 2009;76(1):255-61.

Schulze-Bonhage A. Pharmacokinetic and pharmacodynamic profile of pregabalin and its role in the treatment of epilepsy. Expert Opin Drug Metab Toxicol. 2013;9(1):105-15.

Boomershine CS. Pregabalin for the management of fibromyalgia syndrome. J Pain Res. 2010;3:81-8.

Toth C. Drug safety evaluation of pregabalin. Expert Opin Drug Saf. 2012;11(3):487-502.

Roth T, Bhadra-Brown P, Pitman VW, Resnick EM. Pregabalin improves fibromyalgia-related sleep disturbance. Clin J Pain. 2016;32(4):308-12.

Russell IJ, Crofford LJ, Leon T, Cappelleri JC, Bushmakin AG, Whalen E. The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome. Sleep Med. 2009;10(6):604-10.

Clair A, Emir B. The safety and efficacy of pregabalin for treating subjects with fibromyalgia and moderate or severe baseline widespread pain. Curr Med Res Opin. 2016;32(3):601-9.

Arnold LM, Russell IJ, Diri EW, Duan WR, Young Jr JP, Sharma U. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain. 2008;9(9):792-805.

Arnold LM, Emir B, Pauer L, Resnick M, Clair A. Time to improvement of pain and sleep quality in clinical trials of pregabalin for the treatment of fibromyalgia. Pain Med. 2015;16(1):176-85.

Gilron I, Chaparro LE, Tu D, Holden RR, Milev R, Towheed T. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial. Pain. 2016;157(7):1532-40.

Calandre EP, Morillas-Arques P, Molina-Barea R, Rodriguez-Lopez CM, Rico-Villademoros F. Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study. BMC Musculoskelet Disord. 2011;12(16):1-9.

Arnold LM, Sarzi-Puttini P, Arsenault P, Khan T, Brown P Bhadra, Clair A. Efficacy and safety of pregabalin in patients with fibromyalgia and comorbid depression taking concurrent antidepressant medication: a randomized, placebo-controlled study. J Rheumatol. 2015;42(7):1237-44.

Derry S, Cording M, Wiffen PJ, Law S, Phillips T, Moore RA. Pregabalin for pain in fibromyalgia in adults. Cochrane Database Syst Rev. 2016:CD011790.

Arnold LM, Emir B, Murphy TK, Zeiher BG, Pauer L, Scott G. Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia. Clin Ther. 2012;34(5):1092-102.